Publication: Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
dc.contributor.author | Mihajlovic, Miroslav (57207498211) | |
dc.contributor.author | Simic, Jelena (57201274633) | |
dc.contributor.author | Marinkovic, Milan (56160715300) | |
dc.contributor.author | Kovacevic, Vladan (57190845395) | |
dc.contributor.author | Kocijancic, Aleksandar (36016706900) | |
dc.contributor.author | Mujovic, Nebojsa (16234090000) | |
dc.contributor.author | Potpara, Tatjana S. (57216792589) | |
dc.date.accessioned | 2025-06-12T12:31:32Z | |
dc.date.available | 2025-06-12T12:31:32Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Treatment burden (TB) is defined as the patient’s workload of healthcare and its impact on patient functioning and wellbeing. High TB can lead to non-adherence, a higher risk of adverse outcomes and lower quality of life (QoL). We have previously reported a higher TB in patients with atrial fibrillation (AF) vs. those with other chronic conditions. In this analysis, we explored sex-related differences in self-reported TB in AF patients. Materials and methods: A single-center, prospective study included consecutive patients with AF under drug treatment for at least 6 months before enrollment from April to June 2019. Patients were asked to voluntarily and anonymously answer the Treatment Burden Questionnaire (TBQ). All patients signed the written consent for participation. Results: Of 331 patients (mean age 65.4 ± 10.3 years, mean total AF history 6.41 ± 6.62 years), 127 (38.4%) were females. The mean TB was significantly higher in females compared to males (53.7 vs. 42.6 out of 170 points, p < 0.001), and females more frequently reported TB ≥ 59 points than males (37.8% vs. 20.6%, p = 0.001). In females, on multivariable analysis of the highest TB quartile (TB ≥ 59), non-vitamin K Antagonist Oral Anticoagulant (NOAC) use [Odds Ratio (OR) 0.319; 95% Confidence Interval (CI) 0.12–0.83, P = 0.019], while in males, catheter ablation and/or ECV of AF (OR 0.383; 95% CI 0.18–0.81, P = 0.012) were negatively associated with the highest TB quartile. Conclusion: Our study was the first to explore the sex-specific determinants of TB in AF patients. Females had significantly higher TB compared with males. Approximately 2 in 5 females and 1 in 5 males reported TB ≥ 59 points, previously shown to be an unacceptable burden of treatment for patients. Using a NOAC rather than vitamin K antagonist (VKA) in females and a rhythm control strategy in males could decrease TB to acceptable values. Copyright © 2022 Mihajlovic, Simic, Marinkovic, Kovacevic, Kocijancic, Mujovic and Potpara. | |
dc.identifier.uri | https://doi.org/10.3389/fcvm.2022.1029730 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85142288666&doi=10.3389%2ffcvm.2022.1029730&partnerID=40&md5=205eb1a6a82b0dbeef69a2d8d3572086 | |
dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/3158 | |
dc.subject | atrial fibrillation | |
dc.subject | female sex | |
dc.subject | quality of life | |
dc.subject | sex-related differences | |
dc.subject | treatment burden | |
dc.title | Sex-related differences in self-reported treatment burden in patients with atrial fibrillation | |
dspace.entity.type | Publication |